Percutaneous coronary intervention: Before, after, or during TAVR?

Abstract

Key points Decisions surrounding if, and when, to perform coronary revascularization in patients undergoing trans‐catheter aortic valve replacement (TAVR) are often complex. Concomitant percutaneous coronary interventions (PCI) and TAVR is associated with comparable technical success, but higher rates of bleeding and acute kidney injury, compared to staged procedures or no PCI. Timing of PCI relative to TAVR should be individualized based on clinical status, lesion complexity and anticipated risks of bleeding and renal injury.